Healthy Human
Conditions
Interventions
None listed
Sponsors
Matsutani Chemical Industry Co. Ltd.
Kagawa University, Hokkaido University Hospital, and Izumoring Co. Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study can be found in full report. The study conducted in last 50 years. The study patients are human. The study patients are healthy. The study intervention is allulose. The study patients take some types of meal with the intervention. The study conducts blood glucose measurements at least 2 hours. The study measures total Area Under Curve (AUC) of blood glucose levels or could obtain either one of them from authors' group.
Exclusion criteria
Exclusion criteria: The study is a review or a case study or doesn't report any experiment. The study with control or placebo group can't be found, so that there is no comparison can be done. The part of study patients has certain medical conditions and could not obtain data with only healthy patients. The part of study intervention is allulose and could not obtain data with only allulose intervention. The study doesn't indicate the level of allulose intake. The study doesn't measure total AUC of blood glucose levels for 2 hours or could not obtain a data for 2 hours from authors' group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Does allulose intake (<= 10g) attenuate postprandial blood glucose levels in healthy human? | — |
Secondary
| Measure | Time frame |
|---|---|
| Does lower intake of allulose (<= 5g) attenuate postprandial blood glucose levels in healthy human? In other words, is there any difference in two different doses? | — |
Countries
Japan
Contacts
Public ContactYuma Tani
Matsutani Chemical Industry Co. Ltd. Rare Sugar Business Unit
Outcome results
None listed